InnoCare Pharma (FRA:33C) FCF Yield % : -9.99 (As of May. 15, 2024)

View and export this data going back to 2021. Start your Free Trial

What is InnoCare Pharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, InnoCare Pharma's Trailing 12-Month Free Cash Flow is €-14.06 Mil, and Market Cap is €1,201.81 Mil. Therefore, InnoCare Pharma's FCF Yield % for today is -9.99%.

The historical rank and industry rank for InnoCare Pharma's FCF Yield % or its related term are showing as below:

FRA:33C' s FCF Yield % Range Over the Past 10 Years
Min: -9.99 Med: -0.04 Max: -0.02
Current: -9.99

During the past 7 years, the highest FCF Yield % of InnoCare Pharma was -0.02%. The lowest was -9.99%. And the median was -0.04%.

FRA:33C's FCF Yield % is ranked better than
58.69% of 1554 companies
in the Biotechnology industry
Industry Median: -14.48 vs FRA:33C: -9.99

InnoCare Pharma's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

InnoCare Pharma FCF Yield % Historical Data

The historical data trend for InnoCare Pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnoCare Pharma FCF Yield % Chart

InnoCare Pharma Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-0.02

-4.57

-8.88

InnoCare Pharma Quarterly Data
	Dec17	Sep18	Dec18	Jun19	Sep19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial												-	-	-	-	-5.74

Competitive Comparison of InnoCare Pharma's FCF Yield %

For the Biotechnology subindustry, InnoCare Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InnoCare Pharma's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InnoCare Pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where InnoCare Pharma's FCF Yield % falls into.

InnoCare Pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

InnoCare Pharma's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-118.924	/	1339.9788
	=	-8.88%

InnoCare Pharma's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0	*	4	/	1339.9788
	=	0.00%

InnoCare Pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

InnoCare Pharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of InnoCare Pharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

InnoCare Pharma (FRA:33C) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InnoCare Pharma Ltd (FRA:33C) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

09969:Hong Kong 33C:Germany 688428:China

Address

No. 8 Life Science Park Road, Building 8, Zhongguancun Life Science Park, Changping District, Beijing, CHN, 102206

Website

https://www.innocarepharma.com

InnoCare Pharma Ltd is a commercial-stage biopharmaceutical company. It discovers, develops, and commercializes drugs for the treatment of cancer and autoimmune diseases. The company's main product pipeline includes orelabrutinib, ibrutinib, zanubrutinib, tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-192, ICP-723, and ICP-189, among others. Its products are mainly used to treat hematological tumors, solid tumors, and autoimmune diseases. The company is also developing products for the treatment of autoimmune diseases caused by abnormal B-cell or T-cell function.

InnoCare Pharma (FRA:33C) Headlines

No Headlines